Michael Derrer Fuchs/iStock Editorial through Getty Images
Novartis ( NYSE: NVS) (OTCPK: NVSEF) ( TSX: NVS: CA) stated Sunday it will obtain California-based Avidity Biosciences ( NASDAQ: RNA) in a $12 billion all-cash deal, reinforcing the Swiss pharmaceutical business’s portfolio of treatments for uncommon muscle conditions.
According to the arrangement, Avidity ( NASDAQ: RNA) investors will
Source: Business Insider.
![S&P 500 ETF (SPY) advances with nested structure in wave (five) [Video]](https://thenyledger.com/wp-content/uploads/2025/10/1761626124_169_image-350x250.png "S&P 500 ETF (SPY) advances with nested structure in wave (five) [Video]")
